FDA approves Medtronic's Marquis ICD (implantable cardioverter defibrillator):
This article was originally published in Clinica
Executive Summary
The US FDA has approved for sale the first product in Medtronic's new generation of implantable cardioverter defibrillators (ICDs). The Marquis DR dual-chamber ICD offers a charge time of just 7.5 seconds - ie the time needed before the device delivers a life-saving therapy after an abnormal heart rhythm is detected. The 36cc product also incorporates a battery that can last 7-8 years, resulting in less frequent device replacement for the patient. The device is being launched in the US, Canada and Europe, says the firm.